Role of Glucagon-like Peptide-1 (GLP-1) receptor agonists versus DPP-4 inhibitors for alcohol and substance use disorders in improving HIV-related outcomes and providing health benefits in people living with HIV

HEALTH AND HUMAN SERVICES, DEPARTMENT OF.NATIONAL INSTITUTES OF HEALTH.NATIONAL INSTITUTES OF HEALTH NIDA

Scientific/Technical ConsultingNAICS 541690SAM# 75N95026R0007
Posted 2026-07-27 · Response deadline 2026-07-30 · Set-aside: NONE

https://api.sam.gov/prod/opportunities/v1/noticedesc?noticeid=39c13aa6756e4ac2bc3ab83cc43acf71

View official SAM.gov notice →

← All opportunities